Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines

AIDS Research and Human Retroviruses

Volumn 16, Issue 14, 2000, Pages 1433-1443

  Ferrari, G ^a   Kostyu, D D ^a   Cox, J ^b   Dawson, D V ^c   Flores, J ^d   Weinhold, K J ^a   Osmanov, S ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Henry Jackson Foundation   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNAIDS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPITOPE; GAG PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE FREQUENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM BOVIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VACCINATION;

AIDS VACCINES; ALLELES; AMINO ACID SEQUENCE; CONSERVED SEQUENCE; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; HIV ANTIGENS; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 0034692516     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050140982     Document Type: Article

References (62)

1. Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
2. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: Recognition of autologous virus sequences within a conserved immunodominant epitope
3. Virus-specific CD8+ cytotoxic T lymphocyte activity associated with control viremia in primary human immunodeficiency virus type 1 infection
4. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term non-progressors
5. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS
6. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV type 1 infection
7. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection
8. Human immunodeficiency virus type-1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo
9. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
10. HIV-specific citotoxic T-cells in HIV-exposed but uninfected Gambian women
11. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
12. Cytotoxic T lymphocyte responses in the peripheral blood of children born to HIV-1 infected mother
13. Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals
14. An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum
15. Practical, biochemical and evolutionary implication of the discovery of HLA class I supermotifs
16. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge
17. Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice
18. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians
19. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development
20. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients
21. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection
22. Cross-clade cytotoxic T cell response to HIV-1 proteins among HLA disparate North Americans and Thais
23. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
24. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium boris bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals
25. Recombinant bacillus Calmette-Guerin (rBCG) as potential vectors for preventive HIV vaccines
26. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups
27. Ramifications of HLA class I polymorphism and population genetics on vaccine development
28. Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses
29. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes
30. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency vires type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences
31. Different patterns of HIV-1-specific cytotoxic T lymphocyte activity after primary infection
32. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
33. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins
34. Human irnmunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors
35. Patterns of immunodominance of HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation
36. Human immunodeficiency virus genetic variation that can escape cytotoxic T. cell recognition
37. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
38. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
39. Transmission of HIV-1 subtype E in the United States
40. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS
41. Cellular cytotoxic response induced by DNA vaccination in HIV 1-infected patients
42. Antiviral pressure exerted by HIV-1-specific cytotoxic T limphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
43. Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: Advances in 1994-1995
44. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes
45. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: Effects of viral variation on cytotoxic T-lymphocyte recognition
46. Transfer of HIV-1 specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
47. Antigenic oscillations and shifting immunodominance in HIV-1 infections
48. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
49. Degenerate and promiscuous recognition by CTL of peptides presented by the class I A3-like superfamily
50. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules
51. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in gp160 and reverse transcriptase
52. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection
53. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant
54. Escape of human immunodeficiency virus from immune control
55. Different MHC class I alleles compete for presentation of overlapping viral epitopes
56. Immunodominance in major histo-compatibility complex class I-restricted T lymphocyte responses
57. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
58. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
59. Generation of primary peptide-specific CD8+ cytotoxic T-lymphocytes in vitro using allogeneic dendritic cells
60. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th 1-biasing cytokines
61. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells